Allison M. Manuel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Allison M. Manuel has a total of 91 co-authors. Here are the top co-authors by number of shared publications:
- Chaowei Shang
Department of Biological Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania
19 shared publications - Jeffrey L. Brodsky
Department of Biological Sciences, University of Pittsburgh, Pittsburgh, USA
19 shared publications - Peter Wipf
University of Pittsburgh
19 shared publications - Sara Sannino
Department of Biological Sciences, University of Pittsburgh, PA, USA
19 shared publications - Stacy Gelhaus Wendell
University of Pittsburgh
19 shared publications - Norma Frizzell
Department of Physiology and Neuroscience, University of South Carolina School of Medicine, Columbia, South Carolina
3 shared publications
Latest Publications
- Open Access
Strong Protein Responses to Acute Infection Control General Post-Viral Sequelae and SARS-CoV-2-specific Neurocognitive Sequelae
Summary: After serious infections, many survivors fully recover while others face persistent symptoms including neurocognitive dysfunction, cardiopulmonary instabilities and disabling fatigue, classified broadly as Post-Acute Infection Syndromes (PAIS). Post-Acute Sequelae of COVID19 (PASC) is one special case. To test whether acute infection initiates PAIS, we analyzed proteins in 173 saliva samples collected during severe respiratory viral infections and tracked patient outcomes for five years. We discovered 44 proteins, all derived from interferon stimulated genes, that respond strongly to acute infection. Rates of post-acute syndromes were similar regardless of infection, but the types of Sequelae differed by virus. High expression of 19 proteins predict low General Sequelae rates across all viruses. High expression of 23 overlapping proteins predict low Neurocognitive Sequelae rates only with SARS-CoV-2 infections. We propose that low expressions of these proteins, which control viral replication, innate immunity, and secondary autoimmunity, combine to precipitate PAIS and PASC. Highlights: Acute viral infections elicit interferon stimulated gene (ISG) protein responses. 23 ISG proteins prevent post-infection General Sequelae for all viral infections. 19 ISG proteins prevent post-infection Neurocognitive Sequelae only with SARS-CoV-2. Poor protein responses induce distinct post-viral syndromes with or without COVID19.
Open AccessStrong Protein Responses to Acute Infection Control General Post-Viral Sequelae and SARS-CoV-2-specific Neurocognitive Sequelae
Summary: After serious infections, many survivors fully recover while others face persistent symptoms including neurocognitive dysfunction, cardiopulmonary instabilities and disabling fatigue, classified broadly as Post-Acute Infection Syndromes (PAIS). Post-Acute Sequelae of COVID19 (PASC) is one special case. To test whether acute infection initiates PAIS, we analyzed proteins in 173 saliva samples collected during severe respiratory viral infections and tracked patient outcomes for five years. We discovered 44 proteins, all derived from interferon stimulated genes, that respond strongly to acute infection. Rates of post-acute syndromes were similar regardless of infection, but the types of Sequelae differed by virus. High expression of 19 proteins predict low General Sequelae rates across all viruses. High expression of 23 overlapping proteins predict low Neurocognitive Sequelae rates only with SARS-CoV-2 infections. We propose that low expressions of these proteins, which control viral replication, innate immunity, and secondary autoimmunity, combine to precipitate PAIS and PASC. Highlights: Acute viral infections elicit interferon stimulated gene (ISG) protein responses. 23 ISG proteins prevent post-infection General Sequelae for all viral infections. 19 ISG proteins prevent post-infection Neurocognitive Sequelae only with SARS-CoV-2. Poor protein responses induce distinct post-viral syndromes with or without COVID19.
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure Legend 1 and Supplementary Table 1 from Non-Essential Amino Acid Availability Influences Proteostasis and Breast Cancer Cell Survival During Proteotoxic Stress
Legend to supplementary figure S1 and Table S1 containing a list of reagents and chemicals used to perform the experiments in the manuscript
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure Legend 1 and Supplementary Table 1 from Non-Essential Amino Acid Availability Influences Proteostasis and Breast Cancer Cell Survival During Proteotoxic Stress
Legend to supplementary figure S1 and Table S1 containing a list of reagents and chemicals used to perform the experiments in the manuscript
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from Non-Essential Amino Acid Availability Influences Proteostasis and Breast Cancer Cell Survival During Proteotoxic Stress
S1. Amino acid modulation orchestrates apoptosis when proteostasis is compromised.
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from Non-Essential Amino Acid Availability Influences Proteostasis and Breast Cancer Cell Survival During Proteotoxic Stress
S1. Amino acid modulation orchestrates apoptosis when proteostasis is compromised.
- Open Access
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Data from Non-Essential Amino Acid Availability Influences Proteostasis and Breast Cancer Cell Survival During Proteotoxic Stress
Protein homeostasis (proteostasis) regulates tumor growth and proliferation when cells are exposed to proteotoxic stress, such as during treatment with certain chemotherapeutics. Consequently, cancer cells depend to a greater extent on stress signaling, and require the integrated stress response (ISR), amino acid metabolism, and efficient protein folding and degradation pathways to survive. To define how these interconnected pathways are wired when cancer cells are challenged with proteotoxic stress, we investigated how amino acid abundance influences cell survival when Hsp70, a master proteostasis regulator, is inhibited. We previously demonstrated that cancer cells exposed to a specific Hsp70 inhibitor induce the ISR via the action of two sensors, GCN2 and PERK, in stress-resistant and sensitive cells, respectively. In resistant cells, the induction of GCN2 and autophagy supported resistant cell survival, yet the mechanism by which these events were induced remained unclear. We now report that amino acid availability reconfigures the proteostasis network. Amino acid supplementation, and in particular arginine addition, triggered cancer cell death by blocking autophagy. Consistent with the importance of amino acid availability, which when limited activates GCN2, resistant cancer cells succumbed when challenged with a potentiator for another amino acid sensor, mTORC1, in conjunction with Hsp70 inhibition.Implications:These data position amino acid abundance, GCN2, mTORC1, and autophagy as integrated therapeutic targets whose coordinated modulation regulates the survival of proteotoxic-resistant breast cancer cells.
- 27 November 2025
- Published by American Association for Cancer Research (AACR)
Open AccessData from Non-Essential Amino Acid Availability Influences Proteostasis and Breast Cancer Cell Survival During Proteotoxic Stress
Protein homeostasis (proteostasis) regulates tumor growth and proliferation when cells are exposed to proteotoxic stress, such as during treatment with certain chemotherapeutics. Consequently, cancer cells depend to a greater extent on stress signaling, and require the integrated stress response (ISR), amino acid metabolism, and efficient protein folding and degradation pathways to survive. To define how these interconnected pathways are wired when cancer cells are challenged with proteotoxic stress, we investigated how amino acid abundance influences cell survival when Hsp70, a master proteostasis regulator, is inhibited. We previously demonstrated that cancer cells exposed to a specific Hsp70 inhibitor induce the ISR via the action of two sensors, GCN2 and PERK, in stress-resistant and sensitive cells, respectively. In resistant cells, the induction of GCN2 and autophagy supported resistant cell survival, yet the mechanism by which these events were induced remained unclear. We now report that amino acid availability reconfigures the proteostasis network. Amino acid supplementation, and in particular arginine addition, triggered cancer cell death by blocking autophagy. Consistent with the importance of amino acid availability, which when limited activates GCN2, resistant cancer cells succumbed when challenged with a potentiator for another amino acid sensor, mTORC1, in conjunction with Hsp70 inhibition.Implications:These data position amino acid abundance, GCN2, mTORC1, and autophagy as integrated therapeutic targets whose coordinated modulation regulates the survival of proteotoxic-resistant breast cancer cells.
- Open Access
Proximity proteomics reveals the molecular architecture of phytochrome B photobodies in Arabidopsis thaliana
The red/far-red light photoreceptor phytochrome B (phyB) forms light-induced subnuclear condensates, termed photobodies, that coordinate plant responses to light and temperature. Despite their central role in environmental signaling, the molecular composition of phyB photobodies during their early formation has remained unknown. Here, we established an in planta proximity labeling approach using miniTurbo-based biotinylation in Arabidopsis thaliana to capture proteins associated with phyB photobodies during early de-etiolation. Mass spectrometry identified 42 high-confidence proximal proteins, including 11 known core components and 31 previously unrecognized photobody-associated proteins. Among these, the co-chaperone HOP1 forms light-dependent nuclear condensates that partially co-localize with phyB photobodies. HOP1 condensates are smaller in the wild-type background than in phyB-overexpressing seedlings, and HOP1 overexpression enhanced cotyledon expansion under red light. These findings suggest that HOP1 contributes to photomorphogenesis by stabilizing phyB photobodies and sustaining active phyB signaling. Together, our results reveal that nascent large phyB photobodies function as dynamic hubs integrating chaperone-mediated protein quality control with transcriptional regulation, providing the first in planta proteomic framework for understanding photobody assembly and signaling in plants.
Open AccessProximity proteomics reveals the molecular architecture of phytochrome B photobodies in Arabidopsis thaliana
The red/far-red light photoreceptor phytochrome B (phyB) forms light-induced subnuclear condensates, termed photobodies, that coordinate plant responses to light and temperature. Despite their central role in environmental signaling, the molecular composition of phyB photobodies during their early formation has remained unknown. Here, we established an in planta proximity labeling approach using miniTurbo-based biotinylation in Arabidopsis thaliana to capture proteins associated with phyB photobodies during early de-etiolation. Mass spectrometry identified 42 high-confidence proximal proteins, including 11 known core components and 31 previously unrecognized photobody-associated proteins. Among these, the co-chaperone HOP1 forms light-dependent nuclear condensates that partially co-localize with phyB photobodies. HOP1 condensates are smaller in the wild-type background than in phyB-overexpressing seedlings, and HOP1 overexpression enhanced cotyledon expansion under red light. These findings suggest that HOP1 contributes to photomorphogenesis by stabilizing phyB photobodies and sustaining active phyB signaling. Together, our results reveal that nascent large phyB photobodies function as dynamic hubs integrating chaperone-mediated protein quality control with transcriptional regulation, providing the first in planta proteomic framework for understanding photobody assembly and signaling in plants.
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from Non-essential amino acid availability influences proteostasis and breast cancer cell survival during proteotoxic stress
S1. Amino acid modulation orchestrates apoptosis when proteostasis is compromised.
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from Non-essential amino acid availability influences proteostasis and breast cancer cell survival during proteotoxic stress
S1. Amino acid modulation orchestrates apoptosis when proteostasis is compromised.
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from Non-essential amino acid availability influences proteostasis and breast cancer cell survival during proteotoxic stress
S1. Amino acid modulation orchestrates apoptosis when proteostasis is compromised.
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from Non-essential amino acid availability influences proteostasis and breast cancer cell survival during proteotoxic stress
S1. Amino acid modulation orchestrates apoptosis when proteostasis is compromised.
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure Legend 1 and Supplementary Table 1 from Non-essential amino acid availability influences proteostasis and breast cancer cell survival during proteotoxic stress
Legend to supplementary figure S1 and Table S1 containing a list of reagents and chemicals used to perform the experiments in the manuscript
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure Legend 1 and Supplementary Table 1 from Non-essential amino acid availability influences proteostasis and breast cancer cell survival during proteotoxic stress
Legend to supplementary figure S1 and Table S1 containing a list of reagents and chemicals used to perform the experiments in the manuscript
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Figure Legend 1 and Supplementary Table 1 from Non-essential amino acid availability influences proteostasis and breast cancer cell survival during proteotoxic stress
Legend to supplementary figure S1 and Table S1 containing a list of reagents and chemicals used to perform the experiments in the manuscript
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure Legend 1 and Supplementary Table 1 from Non-essential amino acid availability influences proteostasis and breast cancer cell survival during proteotoxic stress
Legend to supplementary figure S1 and Table S1 containing a list of reagents and chemicals used to perform the experiments in the manuscript
- Open Access
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Data from Non-essential amino acid availability influences proteostasis and breast cancer cell survival during proteotoxic stress
Protein homeostasis (proteostasis) regulates tumor growth and proliferation when cells are exposed to proteotoxic stress, such as during treatment with certain chemotherapeutics. Consequently, cancer cells depend to a greater extent on stress signaling, and require the integrated stress response (ISR), amino acid metabolism, and efficient protein folding and degradation pathways to survive. To define how these interconnected pathways are wired when cancer cells are challenged with proteotoxic stress, we investigated how amino acid abundance influences cell survival when Hsp70, a master proteostasis regulator, is inhibited. We previously demonstrated that cancer cells exposed to a specific Hsp70 inhibitor induce the ISR via the action of two sensors, GCN2 and PERK, in stress-resistant and sensitive cells, respectively. In resistant cells, the induction of GCN2 and autophagy supported resistant cell survival, yet the mechanism by which these events were induced remained unclear. We now report that amino acid availability reconfigures the proteostasis network. Amino acid supplementation, and in particular arginine addition, triggered cancer cell death by blocking autophagy. Consistent with the importance of amino acid availability, which when limited activates GCN2, resistant cancer cells succumbed when challenged with a potentiator for another amino acid sensor, mTORC1, in conjunction with Hsp70 inhibition. Implications: These data position amino acid abundance, GCN2, mTORC1, and autophagy as integrated therapeutic targets whose coordinated modulation regulates the survival of proteotoxic-resistant breast cancer cells.
- 16 September 2024
- Published by American Association for Cancer Research (AACR)
Open AccessData from Non-essential amino acid availability influences proteostasis and breast cancer cell survival during proteotoxic stress
Protein homeostasis (proteostasis) regulates tumor growth and proliferation when cells are exposed to proteotoxic stress, such as during treatment with certain chemotherapeutics. Consequently, cancer cells depend to a greater extent on stress signaling, and require the integrated stress response (ISR), amino acid metabolism, and efficient protein folding and degradation pathways to survive. To define how these interconnected pathways are wired when cancer cells are challenged with proteotoxic stress, we investigated how amino acid abundance influences cell survival when Hsp70, a master proteostasis regulator, is inhibited. We previously demonstrated that cancer cells exposed to a specific Hsp70 inhibitor induce the ISR via the action of two sensors, GCN2 and PERK, in stress-resistant and sensitive cells, respectively. In resistant cells, the induction of GCN2 and autophagy supported resistant cell survival, yet the mechanism by which these events were induced remained unclear. We now report that amino acid availability reconfigures the proteostasis network. Amino acid supplementation, and in particular arginine addition, triggered cancer cell death by blocking autophagy. Consistent with the importance of amino acid availability, which when limited activates GCN2, resistant cancer cells succumbed when challenged with a potentiator for another amino acid sensor, mTORC1, in conjunction with Hsp70 inhibition. Implications: These data position amino acid abundance, GCN2, mTORC1, and autophagy as integrated therapeutic targets whose coordinated modulation regulates the survival of proteotoxic-resistant breast cancer cells.